NCT04511728View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

January 25, 2021

Conditions
Induction and Maintenance of General Anesthesia
Interventions
DRUG

HSK3486

The initial Induction dose of HSK3486 is 0.4 mg/kg. The initial maintenance dose of HSK3486 is 0.8 mg/kg/h

DRUG

Propofol

The initial Induction dose of propofol is 2.0 mg/kg. The initial maintenance dose of propofol is 5.0 mg/kg/h

Trial Locations (1)

Unknown

West China Hospital，Sichuan University, Chengdu

All Listed Sponsors
lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04511728 - A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia | Biotech Hunter | Biotech Hunter